Sabuya, Jose L.
HRN: 19-02-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
CEFTRIAXONE 1G (VIAL)
10/21/2023
10/28/2023
IV
2g
Daily
Indirect InguinalHernia, Right, Irreducible; Hydrocele, Right; S/P Herniorrhaphy (March 2020, MRH)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes